Location
Headquarters: Paris, Ile-de-France, France, Europe
Region: Ile-de-France
Country: FR
Continent: Europe
About
Sanofi is a global biopharmaceutical company focused on research and development-driven medicines and vaccines. It operates across therapeutic areas including immunology, neurology, oncology, and rare diseases, with a commitment to innovative healthcare solutions worldwide. The company emphasizes digital and AI-powered approaches in R&D to advance breakthroughs and improve patient outcomes, pursuing sustainable growth and access to healthcare benefits. Headquartered with global reach, Sanofi engages in external innovation, manufacturing, and patient engagement as part of its strategy to address critical health challenges.
Sanofi is a global biopharmaceutical company that discovers, develops, and delivers innovative medicines and vaccines. It serves patients worldwide across therapeutic areas including immunology, oncology, rare diseases, and neurology. The company also produces over-the-counter medications and emphasizes digital and AI-powered approaches in its research and development.
Sanofi-Aventis, LLC.
1994
for_profit
active
Industries
Primary Industry: Business Services
Categories
Funding & Financials
Public Company
73000000
over-1b
ipo
SNY
nasdaq
Investors
Founders
Jean-François Dehecq
Jean-René Sautier
Leadership
Patricia Roselle — Global Head, Patient Network Management
Franqui Jimenez — Business Partner Rare Disease Cluster, Global MSAT
Christophe Hirtz — Source to Pay project Lead
John O'Malley — Principal Clinical Research Director and Global Clinical Lead, Amlitelimab
Jean-Baptiste Chasseloup de Chatillon — Executive Vice President & CFO
Jean-Pierre Adiceom — Responsable Financier
Rinat Nazmutdinov — Talent Acquisition Partner (Digital, Data & AI)
Robert Castaigne — board_member
Jean-Paul Kress — board_member
Technology Stack
Products
Sarclisa: A medication for treating newly diagnosed multiple myeloma in patients eligible for transplant.
Dupixent: A targeted medicine for treating atopic dermatitis, bullous pemphigoid, and chronic rhinosinusitis with nasal polyps.
Beyfortus: A vaccine product aimed at protecting against respiratory syncytial virus (RSV) infections.
Depakine: A pharmaceutical product used for neurological conditions, including epilepsy.
Aubagio: A treatment for multiple sclerosis to manage disease progression and symptoms.
Vaccines Portfolio: A range of vaccines for prevention of infectious diseases across different age groups.
Funding rounds
Post Ipo Debt · $2.7B · (2026-04-24)
Post Ipo Debt · $3B · (2025-10-28)
Post Ipo Debt · $1.72B · (2025-06-17)
Connect
Connect
Open positions(11)
- Lab Automation Engineer SpecialistFull-timeHybridGent63.102–84.137 / Year
- Device Quality Engineer - Device Risk Management and Surveillance ExcellenceFull-timeWork from OfficeCambridge, MA90,000–130,000 / Year
- Graphic DesignerFull-timeWork from OfficeMorristown, NJ71,250–102,916 / Year
- Accelerator - Software Engineer (Paris)PremiumFull-timeHybridParis64.000–85.333 / Year
- Clinical Scientist, OphthalmologyFull-timeWork from OfficeCambridge, MA148,500–214,500 / Year
- Scientist (Upstream), MSATFull-timeWork from OfficeCity of Singapore
- Data EngineerFull-timeHybridBarcelona49.600–74.400 / Year
- Statistical Data Scientist - Injectables and Tech Transfer.Full-timeWork from OfficeSwiftwater, PA90,000–130,000 / Year
- RWE Data ScientistFull-timeHybridBarcelona70.800–94.400 / Year
- Patient Experience iCare Exchange Python EngineerPremiumFull-timeWork from OfficeHyderabad
- Accelerator Software EngineerFull-timeHybridParis54.400–72.533 / Year